CASE REPORT

 

Chemical abscess post vein of Galen aneurysmal malformation embolisation with ethylene vinyl alcohol copolymer

 

 

Uday Bhanu Kovilapu; Rahul Dudhal; Saurabh Maheshwari; Peeyush Dhagat; Umesh K. Mishra

Department of Radiodiagnosis, Armed Forces Medical College, Pune, India

Correspondence

 

 

---

ABSTRACT

Vein of Galen aneurysmal malformation (VGAM) is a rare congenital malformation characterised by arteriovenous fistulas between primitive choroidal arteries and the median prosencephalic vein, the embryonic precursor to the vein of Galen. Endovascular techniques have changed the management of these patients with improved prognosis. An eight-month-old with VGAM managed by endovascular embolisation using ethylene vinyl alcohol copolymer (EVOH) developed a chemical abscess - a rare complication. It was managed conservatively and showed promising clinical outcome.
CONTRIBUTION: Chemical abscesses following EVOH embolisation are scarce - with imaging differentials, which include brain abscess and onyx granuloma. Knowledge and successful identification of this entity are essential as its management as prognoses differ. Chemical abscess is managed conservatively and has a good prognosis.

Keywords: vein of Galen; endovascular embolisation; ethylene vinyl alcohol copolymer (onyx); chemical abscess; onyx granuloma; brain abscess; VGAM; vein of Galen malformation.

---

 

 

Introduction

Vein of Galen aneurysmal malformations (VGAM) are rare anomalies of the intracranial vasculature, constituting 37.0% of paediatric vascular malformations.¹ They are characterised by arteriovenous fistulas between primitive choroidal arteries and the median prosencephalic vein, the embryonic precursor to the vein of Galen (VOG). The fistula prevents the regression of the median prosencephalic vein and the development of the vein of Galen. It is associated with poor clinical outcomes, with a mortality of 76.7% if left untreated.² With the advent of newer techniques and management strategies, the overall survival with endovascular treatment and technical success is approximately 80.0%.^3,4 This report describes a rare complication of onyx embolisation, a chemical abscess, which was managed conservatively and has favourable long-term results.

 

Case report

An 8-month-old child presented with progressively increasing head size since birth, global developmental delay in achieving age-appropriate milestones (the child's milestones were equivalent to 3 months as per accepted developmental milestones), and cranial bruits. The occipito-frontal circumference was 54 cm (standard for age is 43 cm-45 cm).

Magnetic resonance imaging of the brain revealed a well-circumscribed markedly T2 hypo-intense midline lesion dorsal to the third ventricle, causing mass effect on the aqueduct with resultant dilatation of the lateral and third ventricles and a normal-sized fourth ventricle suggestive of obstructive hydrocephalus. Cerebral digital subtraction angiography confirmed a mural type of VGAM (Lasjaunias classification) with feeders from both posterior cerebral arteries and the left anterior cerebral artery (Figure 1).

Management and outcome

The child proceeded to endovascular management. Right femoral arterial access was acquired with a 5 French(Fr) short sheath, and a 5 Fr guiding catheter was placed through the short sheath and negotiated into the right vertebral artery (V4 Segment). Following this, super selective cannulation of the posteromedial choroidal branches of the right posterior cerebral artery (PCA) was accomplished, and 2 mL of onyx 18 was injected on the arterial side with reflux into the large venous sac, resulting in its occlusion. Complete avascularity of the sac was achieved after occluding the VOG sac. Post embolisation MRI on day three revealed a minimal reduction in the size of the VOG sac, with minimal enhancement of the sac wall and no internal restricted diffusion, as shown in Figure 2.

The child was followed up at regular intervals for 2 years. There was a gradual improvement in achieving developmental milestones. Follow-up MRI after 1 month revealed a residual aneurysmal sac showing wall enhancement, restricted diffusion, and persistent hydrocephalus, as depicted in Figure 3.

A differential diagnosis of brain abscess was considered; however, in view of the gradual improvement in cognitive function, lack of clinical deterioration, and lack of oedema in the surrounding brain parenchyma on MRI, a diagnosis of chemical abscess was made. The child was managed conservatively and followed up. There was further clinical improvement at 6 months post embolisation {developmental milestones equivalent to 10 months of age as per the Centres for Disease Control and Prevention (CDC) criteria}. On MRI there was a reduction in the size of the residual sac and hydrocephalus, albeit with continued restricted diffusion and peripheral mural enhancement, as shown in Figure 4.

After 2 years, the child had achieved milestones commensurate with age. The head circumference was stabilised on examination, and no neurological deficits were present. At this stage, MRI revealed near-total regression of the sac with no residual wall enhancement.

 

Discussion

Vein of Galen aneurysmal malformation is associated with poor clinical outcomes, with a mortality rate of 76.7% if left untreated.² Various treatment modalities include endovascular repair, microsurgery (craniotomy and vascular clip occlusion), and gamma knife surgery. Microsurgery and gamma knife surgery have been reported to have very high mortality and morbidity.⁵ Given this, endovascular techniques have emerged as the standard of care for treating VGAM because of the low complication rate and favourable outcome.^3,4

The options for approaching the embolisation include transarterial, transvenous and transocular, with higher complications reported in the latter two approaches.^6,7 Previously, glue (n-butyl cyanoacrylate) was the standard embolic liquid agent used; however, its characteristics limit precise control of the material during injections. Ethylene vinyl alcohol copolymer (EVOH), dissolved in dimethyl sulfoxide (DMSO) and suspended micronized tantalum powder for visualisation under fluoroscopy, allows a more controlled and more precise embolisation as it is less adhesive and polymerises slowly. It has recently substituted glue for embolising various arteriovenous malformations,^8,9 and was also used in the patient presented. Technical complications are more common in neonates than infants. The complications include near vessel occlusion, haemorrhage and catheter retention.

In the current case, the infant had a mural type of VGAM. Post-embolisation follow-up MRI after 1 month revealed a residual aneurysmal sac showing wall enhancement, restricted diffusion, and persistent hydrocephalus. Brain abscesses, and onyx granuloma formation have been described in case reports as rare complications after endovascular embolisation of brain arteriovenous malformations. They should be considered in the differential diagnosis as their management is different. Brain abscess requires drainage and specific antibiotic therapy. Onyx granulomas are usually self-limiting and require treatment only when progressive and symptomatic.¹⁰ Diffusion-weighted imaging has been recommended to differentiate between abscess and granuloma, with abscess showing restricted diffusion.¹¹

The second and third follow-up MRI indicated thick mural enhancement and marked restricted diffusion. However, a benign aetiology of chemical abscess was considered as there was progressive clinical improvement, regaining of developmental milestones, no further decline in neurological development, and no oedema of the surrounding brain parenchyma on T2WI/FLAIR images. Subsequent follow-up 6 months post embolisation showed even further clinical improvement. Magnetic resonance imaging showed a reduction in the size of the residual sac and hydrocephalus, albeit with continued restricted diffusion and peripheral mural enhancement, as shown in Figure 4. The continuing clinical improvement and reduction in size confirmed the diagnosis. Further MRI after 2 years revealed near-total regression in the sac with no significant wall enhancement.

A possible cause of the persisting enhancement could be the inflammatory response in the walls of the embolised vessel because of the onyx material. Microscopically, multinucleated giant cells have been demonstrated in onyx granuloma.¹¹ A rare complication of intravascular onyx injection causing the formation of the cerebral abscess has been reported.¹² However, an infective aetiology was not considered in the case presented as there was no clinical deterioration or new neurological deficit. The diagnosis of chemical abscess was made based on the clinical and radiological findings, which consolidated and reduced in size over 2 years.

 

Conclusion

The introduction of endovascular treatment has revolutionised the management of VGAM. Although chemical abscess formation after embolisation is exceedingly rare, it is a benign condition that should be differentiated from an infectious abscess. Interventional neuro-radiologists and paediatricians should be vigilant about this complication to avoid unnecessary intervention. However, patients will require regular follow-up to assess the course and regression of the chemical abscess.

 

Acknowledgements

Competing interests

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Authors' contributions

The authors confirm their contribution to the paper as follows: study conception and design, U.B.K., P.D.; data collection, U.B.K., P.D.; analysis and interpretation of results, U.B.K., R.D.; draft manuscript preparation, U.B.K., S.M., U.K.M. All authors reviewed the results and approved the final version of the manuscript.

Ethical considerations

An application for full ethical approval was made to the Institutional Review Board, Armed Forces Medical College, Pune, India, and ethics consent was received on 08 November 2021. The ethics approval number is IEC/2021/237. The statements of written informed consent from legally authorised representatives are available. The study was conducted in accordance with the Helsinki Declaration as revised in 2013.

Funding information

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Data availability

The data that support the findings of this study are available from the corresponding author, S.M., upon request.

Disclaimer

The views expressed in the submitted article are of authors and not an official position of the institution, funder or publisher.

 

References

1.Yan J, Gopaul R, Wen J, Li X-S, Tang J-F. The natural progression of VGAMs and the need for urgent medical attention: A systematic review and meta-analysis. J Neurointerv Surg. 2017;9(6):564-570. https://doi.org/10.1136/neurintsurg-2015-012212        [ Links ]

2.Chow ML, Cooke DL, Fullerton HJ, et al. Radiological and clinical features of vein of Galen malformations. J Neurointerv Surg. 2015;7(6):443-448. https://doi.org/10.1136/neurintsurg-2013-011005        [ Links ]

3.Berenstein A, Fifi JT, Niimi Y, et al. Vein of Galen malformations in neonates: New management paradigms for improving outcomes. Neurosurgery. 2012;70(5):1207-1213. https://doi.org/10.1227/NEU.0b013e3182417be3        [ Links ]

4.Jones BV, Ball WS, Tomsick TA, Millard J, Crone KR. Vein of Galen malformation: Diagnosis and treatment of 13 children with extended clinical follow-up. AJNR Am J Neuroradiol. 2002;23(10):1717-1724.         [ Links ]

5.Ellis JA. Cognitive and functional status after vein of Galen aneurysmal malformation endovascular occlusion. World J Radiol. 2012;4(3):83. https://doi.org/10.4329/wjr.v4.i3.83        [ Links ]

6.Deloison B, Chalouhi GE, Sonigo P, et al. Hidden mortality of prenatally diagnosed vein of Galen aneurysmal malformation: Retrospective study and review of the literature. Ultrasound Obstet Gynecol. 2012;40(6):652-658. https://doi.org/10.1002/uog.11188        [ Links ]

7.Kim DJ, Suh DC, Kim BM, Kim DI. Adjuvant coil assisted glue embolization of vein of Galen aneurysmal malformation in pediatric patients. Neurointervention. 2018;13(1):41-47. https://doi.org/10.5469/neuroint.2018.13.1.41        [ Links ]

8.Orlov K, Gorbatykh A, Berestov V, et al. Super selective transvenous embolization with Onyx and n-BCA for vein of Galen aneurysmal malformations with restricted transarterial access: Safety, efficacy, and technical aspects. Childs Nerv Syst. 2017;33(11):2003-2010. https://doi.org/10.1007/s00381-017-3499-6        [ Links ]

9.Gunawat P, Shaikh ST, Karmarkar V, Deopujari C. Symptomatic granuloma secondary to embolic agent: A case report. J Clin Diagn Res. 2016;10(11):PD15-PD16. https://doi.org/10.7860/JCDR/2016/22705.8836        [ Links ]

10.Jabre R, Bernat AL, Peres R, Froelich S. Brain abscesses after endovascular embolization of a brain arteriovenous malformation with Squid. World Neurosurg. 2019;132:29-32. https://doi.org/10.1016/j.wneu.2019.08.095        [ Links ]

11.Jahan R, Murayama Y, Gobin YP, Duckwiler GR, Vinters HV, Viñuela F. Embolization of arteriovenous malformations with Onyx: Clinicopathological experience in 23 patients. Neurosurgery. 2001;48(5):984-995; discussion 995-7. https://doi.org/10.1097/00006123-200105000-00003        [ Links ]

12.Shah KA, Katz JM, Dehdashti AR. Cerebral abscess after Onyx embolization of an arteriovenous malformation. World Neurosurg. 2020;135:96-99. https://doi.org/10.1016/j.wneu.2019.12.009        [ Links ]

 

 

Correspondence:
Saurabh Maheshwari
saurabhmhshwr@yahoo.co.in

Received: 22 Dec. 2023
Accepted: 15 Mar. 2024
Published: 30 Apr. 2024